Hyperbaric Oxygen for Cerebral Vasospasm and Brain Injury Following Subarachnoid Hemorrhage

Translational Stroke Research

Volumn 2, Issue 3, 2011, Pages 316-327

  Ostrowski, Robert P ^a   Zhang, John H ^a,b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cerebral vasospasm; Hyperbaric oxygen; Intracranial aneurysm; Neurological deficits; Neuroprotection; Subarachnoid hemorrhage

Indexed keywords

BILIRUBIN; CASPASE 3; CD18 ANTIGEN; CYCLINE; DNA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; L SELECTIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSIN LIGHT CHAIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; PROTEIN BNIP3; PROTEIN KINASE C; PROTEIN P53; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; RHO KINASE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

APOPTOSIS; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; BRAIN VASOSPASM; DNA STRAND BREAKAGE; HUMAN; HYPERBARIC OXYGEN; INFLAMMATION; ISCHEMIC PRECONDITIONING; MOLECULAR DYNAMICS; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SPREADING CORTICAL DEPRESSION; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOCONSTRICTION;

EID: 80052267974     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-011-0069-1     Document Type: Review

References (133)

1. Keyrouz SG, Diringer MN. Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care. 2007; 11(4): 220.
2. Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol. 2007; 3(5): 256-63.
3. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008; 39(11): 3015-21.
4. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg. 2005; 103(1): 9-17.
5. Hansen-Schwartz J, Vajkoczy P, Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci. 2007; 28(6): 252-25.
6. Ostrowski RP, Colohan AR, Zhang JH. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res. 2006; 28(4): 399-414.
7. Kusaka G, Ishikawa M, Nanda A, Granger DN, Zhang JH. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004; 24(8): 916-25.
8. Stuart RM, Helbok R, Kurtz P, Schmidt M, Fernandez L, Lee K et al. High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism. Neurosurgery. 2011 (in press).
9. Zubkov AY, Rabinstein AA. Medical management of cerebral vasospasm: present and future. Neurol Res. 2009; 31(6): 626-31.
10. Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 2010; 14(1): R23.
11. Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S, et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res. 2009; 31(2): 151-8.
12. Kasuya H. Clinical trial of nicardipine prolonged-release implants for preventing cerebral vasospasm: multicenter cooperative study in Tokyo. Acta Neurochir Suppl. 2011; 110(2): 165-7.
13. Ostrowski RP, Colohan AR, Zhang JH. Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2005; 25(5): 554-71.
14. Kohshi K, Yokota A, Konda N, Kinoshita Y, Kajiwara H. Intracranial pressure responses during hyperbaric oxygen therapy. Neurol Med Chir (Tokyo). 1991; 31(9): 575-81.
15. Kohshi K, Yokota A, Konda N, Munaka M, Yasukouchi H. Hyperbaric oxygen therapy adjunctive to mild hypertensive hypervolemia for symptomatic vasospasm. Neurol Med Chir (Tokyo). 1993; 33(2): 92-9.
16. Isakov I, Pravdenkova SV, Shchelkovskii VN. [Hyperbaric oxygenation in ruptured cerebral aneurysms during the postoperative period]. Zh Vopr Neirokhir Im NN Burdenko. 1985;(3): 17-21.
17. Levina OA, Romasenko MV, Krylov V. Therapeutic effects of hyperbaric oxygenation (HBO) on acute cerebral ischemia in patients after intracranial aneurysms clipping. Eur J Underw Hyperb Med. 2002; 3: 83.
18. Ohta H, Suzuki E, Hinuma Y, Kawamura S, Nemoto M, Hadeishi H. Effects of hyperoxia, glycerol and ventricular drainage on ICP and CBF in patients with increased ICP due to CSF circulatory-absorbance disturbance. No To Shinkei. 1987; 39(3): 273-9.
19. Kawamura S, Ohta H, Yasui N, Nemoto M, Hinuma Y, Suzuki E. Effects of hyperbaric oxygenation in patients with subarachnoid hemorrhage. J Hyperb Med. 1988; 3: 243-56.
20. Ugriumov VM, Elinskii MP, Rafikov AM, Kesaev SA. [Hyperbaric oxygenation in the complex treatment of patients with aneurysms of the cerebral vessels]. Zh Vopr Neirokhir Im NN Burdenko. 1980;(4): 49-54.
21. Kitaoka K, Nakagawa Y, Abe H, Satoh M, Iwakuma T. Hyperbaric oxygenation for the mental conditions following surgery of aneurysm of the anterior communicating artery. Hokkaido Igaku Zasshi. 1983; 58(2): 154-61.
22. Takata K, Sheng H, Borel CO, Laskowitz DT, Warner DS, Lombard FW. Simvastatin treatment duration and cognitive preservation in experimental subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2009; 21(4): 326-33.
23. Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2003; 2(10): 614-21.
24. Walid SM, Zaytseva NV. Quadruple H therapy for vasospasm. Ann Indian Acad Neurol. 2009; 12: 22-4.
25. McHedlishvili G, Varazashvili M, Mamaladze A, Momtselidze N. Blood flow structuring and its alterations in capillaries of the cerebral cortex. Microvasc Res. 1997; 53(3): 201-10.
26. Dhar R, Zazulia AR, Videen TO, Zipfel GJ, Derdeyn CP, Diringer MN. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke. 2009; 40(9): 3039-44.
27. Kocaogullar Y, Ustun ME, Avci E, Karabacakoglu A, Fossett D. The role of hyperbaric oxygen in the management of subarachnoid hemorrhage. Intensive Care Med. 2004; 30(1): 141-6.
28. Imperatore F, Cuzzocrea S, Luongo C, Liguori G, Scafuro A, De Angelis A, et al. Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome. Intensive Care Med. 2004; 30(6): 1175-81.
29. Huang ZX, Kang ZM, Gu GJ, Peng GN, Yun L, Tao HY, et al. Therapeutic effects of hyperbaric oxygen in a rat model of endothelin-1-induced focal cerebral ischemia. Brain Res. 2007; 1153: 204-13.
30. Sharkey J, Butcher SP, Kelly JS. Endothelin-1 induced middle cerebral artery occlusion: pathological consequences and neuroprotective effects of MK801. J Auton Nerv Syst. 1994; 49(Suppl): S177-85.
31. Gaetani P, Baena R, Grignani G, Spanu G, Pacchiarini L, Paoletti P. Endothelin and aneurysmal subarachnoid haemorrhage: a study of subarachnoid cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1994; 57(1): 66-72.
32. Hansen-Schwartz J, Ansar S, Edvinsson L. Cerebral vasoconstriction after subarachnoid hemorrhage-role of changes in vascular receptor phenotype. Front Biosci. 2008; 13: 2160-4.
33. Hansen-Schwartz J, Hoel NL, Zhou M, Xu CB, Svendgaard NA, Edvinsson L. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery. 2003; 52(5): 1188-94.
34. Edvinsson L. Cerebrovascular endothelin receptor upregulation in cerebral ischemia. Curr Vasc Pharmacol. 2009; 7(1): 26-33.
35. Rothoerl RD, Ringel F. Molecular mechanisms of cerebral vasospasm following aneurysmal SAH. Neurol Res. 2007; 29(7): 636-42.
36. Hirata Y, Yoshimi H, Takaichi S, Yanagisawa M, Masaki T. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett. 1988; 239(1): 13-7.
37. Lan C, Das D, Wloskowicz A, Vollrath B. Endothelin-1 modulates hemoglobin-mediated signaling in cerebrovascular smooth muscle via RhoA/Rho kinase and protein kinase C. Am J Physiol Heart Circ Physiol. 2004; 286(1): H165-73.
38. Miao L, Dai Y, Zhang J. Mechanism of RhoA/Rho kinase activation in endothelin-1-induced contraction in rabbit basilar artery. Am J Physiol Heart Circ Physiol. 2002; 283(3): H983-9.
39. Zhou C, Li Y, Nanda A, Zhang JH. HBO suppresses Nogo-A, Ng-R, or RhoA expression in the cerebral cortex after global ischemia. Biochem Biophys Res Commun. 2003; 309(2): 368-76.
40. Sheth MV, Goodman BE, Friese JL, Eyster KM. Protein kinase and phosphatase activity in the lungs of normoxic versus hyperoxic rats. Exp Lung Res. 1997; 23(6): 475-94.
41. Wang X, Wang Y, Kim HP, Choi AM, Ryter SW. FLIP inhibits endothelial cell apoptosis during hyperoxia by suppressing Bax. Free Radic Biol Med. 2007; 42(10): 1599-609.
42. Laher I, Zhang JH. Protein kinase C and cerebral vasospasm. J Cereb Blood Flow Metab. 2001; 21(8): 887-906.
43. Koide M, Nishizawa S, Ohta S, Yokoyama T, Namba H. Chronological changes of the contractile mechanism in prolonged vasospasm after subarachnoid hemorrhage: from protein kinase C to protein tyrosine kinase. Neurosurgery. 2002; 51(6): 1468-74.
44. Tang H, Hao Q, Rutherford SA, Low B, Zhao ZJ. Inactivation of SRC family tyrosine kinases by reactive oxygen species in vivo. J Biol Chem. 2005; 280(25): 23918-25.
45. Kusaka G, Kimura H, Kusaka I, Perkins E, Nanda A, Zhang JH. Contribution of Src tyrosine kinase to cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 2003; 99(2): 383-90.
46. Yamaguchi M, Zhou C, Nanda A, Zhang JH. Ras protein contributes to cerebral vasospasm in a canine double-hemorrhage model. Stroke. 2004; 35(7): 1750-5.
47. Yatsushige H, Yamaguchi-Okada M, Zhou C, Calvert JW, Cahill J, Colohan AR, et al. Inhibition of c-Jun N-terminal kinase pathway attenuates cerebral vasospasm after experimental subarachnoid hemorrhage through the suppression of apoptosis. Acta Neurochir Suppl. 2008; 104: 27-31.
48. Nosko M, Weir BK, Lunt A, Grace M, Allen P, Mielke B. Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model. J Neurosurg. 1987; 66(3): 416-22.
49. Crowley RW, Medel R, Kassell NF, Dumont AS. New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage. Drug Discov Today. 2008; 13(5-6): 254-60.
50. Guney O, Erdi F, Esen H, Kiyici A, Kocaogullar Y. N-acetylcysteine prevents vasospasm after subarachnoid hemorrhage. Surg Neurol. 2010; 73: 42-9.
51. Munakata A, Ohkuma H, Shimamura N. Effect of a free radical scavenger, edaravone, on free radical reactions: related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model. Acta Neurochir Suppl. 2011; 110(2): 17-22.
52. Nakamura K, Koga Y, Sakai H, Homma K, Ikebe M. cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase. Circ Res. 2007; 101(7): 712-22.
53. Kehl F, Cambj-Sapunar L, Maier KG, Miyata N, Kametani S, Okamoto H, et al. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat. Am J Physiol Heart Circ Physiol. 2002; 282(4): H1556-65.
54. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007; 87(1): 315-424.
55. Ostrowski RP, Tang J, Zhang JH. Hyperbaric oxygen suppresses NADPH oxidase in a rat subarachnoid hemorrhage model. Stroke. 2006; 37(5): 1314-8.
56. Kim DE, Suh YS, Lee MS, Kim KY, Lee JH, Lee HS, et al. Vascular NAD(P)H oxidase triggers delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke. 2002; 33(11): 2687-91.
57. Zheng JS, Zhan RY, Zheng SS, Zhou YQ, Tong Y, Wan S. Inhibition of NADPH oxidase attenuates vasospasm after experimental subarachnoid hemorrhage in rats. Stroke. 2005; 36(5): 1059-64.
58. Matsubara M, Hayashi N, Jing T, Titani K. Regulation of endothelial nitric oxide synthase by protein kinase C. J Biochem. 2003; 133(6): 773-81.
59. Hink J, Thom SR, Simonsen U, Rubin I, Jansen E. Vascular reactivity and endothelial NOS activity in rat thoracic aorta during and after hyperbaric oxygen exposure. Am J Physiol Heart Circ Physiol. 2006; 291(4): H1988-98.
60. Elayan IM, Axley MJ, Prasad PV, Ahlers ST, Auker CR. Effect of hyperbaric oxygen treatment on nitric oxide and oxygen free radicals in rat brain. J Neurophysiol. 2000; 83(4): 2022-9.
61. Chavko M, Braisted JC, Outsa NJ, Harabin AL. Role of cerebral blood flow in seizures from hyperbaric oxygen exposure. Brain Res. 1998; 791(1-2): 75-82.
62. Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev. 2009; 61(1): 62-97.
63. Qin Z, Xi G, Keep RF, Silbergleit R, He Y, Hua Y. Hyperbaric oxygen for experimental intracerebral hemorrhage. Acta Neurochir Suppl. 2008; 105: 113-7.
64. Zhou C, Yamaguchi M, Kusaka G, Schonholz C, Nanda A, Zhang JH. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004; 24(4): 419-31.
65. Zubkov AY, Ogihara K, Bernanke DH, Parent AD, Zhang J. Apoptosis of endothelial cells in vessels affected by cerebral vasospasm. Surg Neurol. 2000; 53(3): 260-6.
66. Kimura H, Gules I, Meguro T, Zhang JH. Cytotoxicity of cytokines in cerebral microvascular endothelial cell. Brain Res. 2003; 990(1-2): 148-56.
67. Iseda K, Ono S, Onoda K, Satoh M, Manabe H, Nishiguchi M, et al. Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage. J Neurosurg. 2007; 107(1): 128-35.
68. Zhang Q, Chang Q, Cox RA, Gong X, Gould LJ. Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model. J Invest Dermatol. 2008; 128(8): 2102-12.
69. Godman CA, Joshi R, Giardina C, Perdrizet G, Hightower LE. Hyperbaric oxygen treatment induces antioxidant gene expression. Ann NY Acad Sci. 2010; 1197: 178-83.
70. Tompach PC, Lew D, Stoll JL. Cell response to hyperbaric oxygen treatment. Int J Oral Maxillofac Surg. 1997; 26(2): 82-6.
71. Pluta RM. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Acta Neurochir Suppl. 2008; 104: 139-47.
72. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery. 2003; 53(1): 123-33.
73. Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S, et al. Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke. 2009; 40(7): 2519-25.
74. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, et al. Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke. 2000; 31(12): 2971-5.
75. Takeuchi H, Tanabe M, Okamoto H, Yamazaki M. Effects of thromboxane synthetase inhibitor (RS-5186) on experimentally-induced cerebral vasospasm. Neurol Res. 1999; 21(5): 513-6.
76. Satoh S, Suzuki Y, Harada T, Ikegaki I, Asano T, Shibuya M, et al. The role of platelets in the development of cerebral vasospasm. Brain Res Bull. 1991; 27(5): 663-8.
77. Prunell GF, Svendgaard NA, Alkass K, Mathiesen T. Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery. 2005; 56(5): 1082-92.
78. Alex J, Laden G, Cale AR, Bennett S, Flowers K, Madden L, et al. Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: a prospective randomized double-blind trial. J Thorac Cardiovasc Surg. 2005; 130(6): 1623-30.
79. Lin CL, Dumont AS, Calisaneller T, Kwan AL, Hwong SL, Lee KS. Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm. Surg Neurol. 2005; 64(3): 201-5.
80. Bavbek M, Polin R, Kwan AL, Arthur AS, Kassell NF, Lee KS. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke. 1998; 29(9): 1930-5.
81. Polin RS, Bavbek M, Shaffrey ME, Billups K, Bogaev CA, Kassell NF, et al. Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg. 1998; 89(4): 559-67.
82. Buras JA, Stahl GL, Svoboda KK, Reenstra WR. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS. Am J Physiol Cell Physiol. 2000; 278(2): C292-302.
83. Gunther A, Kuppers-Tiedt L, Schneider PM, Kunert I, Berrouschot J, Schneider D, et al. Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia. Eur J Neurosci. 2005; 21(11): 3189-94.
84. Liu JR, Zhao Y, Patzer A, Staak N, Boehm R, Deuschl G, et al. The JNK-inhibitor XG-102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats. Neuropathol Appl Neurobiol. 2010; 36: 211-24.
85. Cahill J, Calvert JW, Solaroglu I, Zhang JH. Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage. Stroke. 2006; 37(7): 1868-74.
86. Kozniewska E, Michalik R, Rafalowska J, Gadamski R, Walski M, Frontczak-Baniewicz M, et al. Mechanisms of vascular dysfunction after subarachnoid hemorrhage. J Physiol Pharmacol. 2006; 57 Suppl 11: 145-60.
87. Grote E, Hassler W. The critical first minutes after subarachnoid hemorrhage. Neurosurgery. 1988; 22(4): 654-61.
88. Hoffman WE, Wheeler P, Edelman G, Charbel FT, Torres NJ, Ausman JI. Hypoxic brain tissue following subarachnoid hemorrhage. Anesthesiology. 2000; 92(2): 442-6.
89. Hishikawa T, Ono S, Ogawa T, Tokunaga K, Sugiu K, Date I. Effects of deferoxamine-activated hypoxia-inducible factor-1 on the brainstem after subarachnoid hemorrhage in rats. Neurosurgery. 2008; 62(1): 232-40.
90. Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiol Bethesda. 2009; 24: 97-106.
91. Schmidt-Kastner R, Aguirre-Chen C, Kietzmann T, Saul I, Busto R, Ginsberg MD. Nuclear localization of the hypoxia-regulated pro-apoptotic protein BNIP3 after global brain ischemia in the rat hippocampus. Brain Res. 2004; 1001(1-2): 133-42.
92. Jeon H, Ai J, Sabri M, Tariq A, Shang X, Chen G, et al. Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage. BMC Neurosci. 2009; 10: 103.
93. Cahill J, Calvert JW, Marcantonio S, Zhang JH. p53 may play an orchestrating role in apoptotic cell death after experimental subarachnoid hemorrhage. Neurosurgery. 2007; 60(3): 531-45.
94. Yan J, Chen C, Lei J, Yang L, Wang K, Liu J, et al. 2-Methoxyestradiol reduces cerebral vasospasm after 48 hours of experimental subarachnoid hemorrhage in rats. Exp Neurol. 2006; 202(2): 348-56.
95. Yan JH, Yang XM, Chen CH, Hu Q, Zhao J, Shi XZ, et al. Pifithrin-alpha reduces cerebral vasospasm by attenuating apoptosis of endothelial cells in a subarachnoid haemorrhage model of rat. Chin Med J Engl. 2008; 121(5): 414-9.
96. Calvert JW, Cahill J, Yamaguchi-Okada M, Zhang JH. Oxygen treatment after experimental hypoxia-ischemia in neonatal rats alters the expression of HIF-1alpha and its downstream target genes. J Appl Physiol. 2006; 101(3): 853-65.
97. Tjarnstrom J, Holmdahl L, Falk P, Falkenberg M, Arnell P, Risberg B. Effects of hyperbaric oxygen on expression of fibrinolytic factors of human endothelium in a simulated ischaemia/reperfusion situation. Scand J Clin Lab Invest. 2001; 61(7): 539-45.
98. Sehba FA, Mostafa G, Friedrich Jr V, Bederson JB. Acute microvascular platelet aggregation after subarachnoid hemorrhage. J Neurosurg. 2005; 102(6): 1094-100.
99. Padgaonkar VA, Giblin FJ, Fowler K, Leverenz VR, Reddan JR, Dziedzic DC. Heme oxygenase synthesis is induced in cultured lens epithelium by hyperbaric oxygen or puromycin. Exp Eye Res. 1997; 65(3): 435-43.
100. Chang KY, Tsai PS, Huang TY, Wang TY, Yang S, Huang CJ. HO-1 mediates the effects of HBO pretreatment against sepsis. J Surg Res. 2006; 136(1): 143-53.
101. Pearl JD, Macdonald RL. Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study. Acta Neurochir Suppl. 2008; 105: 207-10.
102. Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J, et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain. 2009; 132(Pt 7): 1866-81.
103. Kleeberg J, Petzold GC, Major S, Dirnagl U, Dreier JP. ET-1 induces cortical spreading depression via activation of the ETA receptor/phospholipase C pathway in vivo. Am J Physiol Heart Circ Physiol. 2004; 286(4): H1339-46.
104. +)ATPase with ouabain induces spreading depression-like depolarization in hippocampal slices. Brain Res. 1999; 838(1-2): 37-44.
105. +, K(+)-ATPase and membrane fluidity of cerebrocortical membranes after experimental subarachnoid hemorrhage. Neurochem Res. 1993; 18(9): 1033-9.
106. Titova E, Ostrowski RP, Zhang JH, Tang J. Experimental models of subarachnoid hemorrhage for studies of cerebral vasospasm. Neurol Res. 2009; 31(6): 568-81.
107. Li Y, Zhou C, Calvert JW, Colohan AR, Zhang JH. Multiple effects of hyperbaric oxygen on the expression of HIF-1 alpha and apoptotic genes in a global ischemia-hypotension rat model. Exp Neurol. 2005; 191(1): 198-210.
108. Gu GJ, Li YP, Peng ZY, Xu JJ, Kang ZM, Xu WG, et al. Mechanism of ischemic tolerance induced by hyperbaric oxygen preconditioning involves upregulation of hypoxia-inducible factor-1alpha and erythropoietin in rats. J Appl Physiol. 2008; 104(4): 1185-91.
109. Cash TP, Pan Y, Simon MC. Reactive oxygen species and cellular oxygen sensing. Free Radic Biol Med. 2007; 43(9): 1219-25.
110. Jones NM, Lee EM, Brown TG, Jarrott B, Beart PM. Hypoxic preconditioning produces differential expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and its regulatory enzyme HIF prolyl hydroxylase 2 in neonatal rat brain. Neurosci Lett. 2006; 404(1-2): 72-7.
111. Chen W, Ostrowski RP, Obenaus A, Zhang JH. Prodeath or prosurvival: two facets of hypoxia inducible factor-1 in perinatal brain injury. Exp Neurol. 2009; 216(1): 7-15.
112. Halterman MW, Miller CC, Federoff HJ. Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci. 1999; 19(16): 6818-24.
113. Grasso G. An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage. Brain Res Brain Res Rev. 2004; 44(1): 49-63.
114. + channel dysfunction in myocytes from a dog model of subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2008; 28(4): 797-811.
115. Sobey CG. Cerebrovascular dysfunction after subarachnoid haemorrhage: novel mechanisms and directions for therapy. Clin Exp Pharmacol Physiol. 2001; 28(11): 926-9.
116. + channels in cerebral arteries by enhanced tyrosine kinase activity. Circ Res. 2006; 99(11): 1252-60.
117. Jahromi BS, Aihara Y, Ai J, Zhang ZD, Weyer G, Nikitina E, et al. Temporal profile of potassium channel dysfunction in cerebrovascular smooth muscle after experimental subarachnoid haemorrhage. Neurosci Lett. 2008; 440(1): 81-6.
118. Lou M, Chen Y, Ding M, Eschenfelder CC, Deuschl G. Involvement of the mitochondrial ATP-sensitive potassium channel in the neuroprotective effect of hyperbaric oxygenation after cerebral ischemia. Brain Res Bull. 2006; 69(2): 109-16.
119. Colantuono G, Tiravanti EA, Di Venosa N, Cazzato A, Rastaldo R, Cagiano R, et al. Hyperoxia confers myocardial protection in mechanically ventilated rats through the generation of free radicals and opening of mitochondrial ATP-sensitive potassium channels. Clin Exp Pharmacol Physiol. 2008; 35(1): 64-71.
120. Parekh AB, Putney Jr JW. Store-operated calcium channels. Physiol Rev. 2005; 85(2): 757-810.
121. 2+ in subarachnoid hemorrhage-induced spasm of the rabbit basilar artery. Stroke. 1996; 27(10): 1896-902.
122. Veltkamp R, Bieber K, Wagner S, Beynon C, Siebing DA, Veltkamp C, et al. Hyperbaric oxygen reduces basal lamina degradation after transient focal cerebral ischemia in rats. Brain Res. 2006; 1076(1): 231-7.
123. McGirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002; 51(5): 1128-34.
124. Ostrowski RP, Jadhav V, Chen W, Zhang JH. Reduced matrix metalloproteinase-9 activity and cell death after global ischemia in the brain preconditioned with hyperbaric oxygen. Acta Neurochir Suppl. 2010; 106: 47-9.
125. Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 2009; 8(4): 398-412.
126. Keep RF, Wang MM, Xiang J, Hua Y, Xi G. Is there a place for cerebral preconditioning in the clinic? Transl Stroke Res. 2010; 1(1): 4-18.
127. Gidday JM. Pharmacologic preconditioning: translating the promise. Transl Stroke Res. 2010; 1(1): 19-30.
128. Kunz A, Park L, Abe T, Gallo EF, Anrather J, Zhou P, et al. Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species. J Neurosci. 2007; 27(27): 7083-93.
129. Godman CA, Chheda KP, Hightower LE, Perdrizet G, Shin DG, Giardina C. Hyperbaric oxygen induces a cytoprotective and angiogenic response in human microvascular endothelial cells. Cell Stress Chaperones. 2010; 15: 431-42.
130. Lee CC, Chen SC, Tsai SC, Wang BW, Liu YC, Lee HM, et al. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells. J Biomed Sci. 2006; 13(1): 143-56.
131. Sato H, Bolli R, Rokosh GD, Bi Q, Dai S, Shirk G, et al. The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats. Am J Physiol Heart Circ Physiol. 2007; 293(4): H2557-64.
132. Zhang N, Gao G, Bu X, Han S, Fang L, Li J. Neuron-specific phosphorylation of c-Jun N-terminal kinase increased in the brain of hypoxic preconditioned mice. Neurosci Lett. 2007; 423(3): 219-24.
133. Granziera C, Thevenet J, Price M, Wiegler K, Magistretti PJ, Badaut J, et al. Thrombin-induced ischemic tolerance is prevented by inhibiting c-Jun N-terminal kinase. Brain Res. 2007; 1148: 217-25.